Research Article
Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX
Table 5
Comparative differences in incidence rate of neurological adverse effects between each treatment arm of FOLFOX.
| |||||||||||||||||||||||||||||||||||||||
| P value < 0.05 (significant), P value < 0.01 (highly significant), and P value < 0.001 (very highly significant). | |||||||||||||||||||||||||||||||||||||||